FDA NDC Directory · JSON-LD · Markdown

Sodium Polystyrene Sulfonate

NDC 62135-340 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerChartwell RX, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA206815
Dosage form / routePOWDER, FOR SUSPENSION · ORAL RECTAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (4.1 meq/g)
Marketing started20160218
Package count3

External sources

Source: openFDA. Public-domain (CC0).